CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$111.62
−1.05%Forward multiples
Based on analyst estimates
- P/E forward
- 27.98x
- P/E 2026E
- 53.50x
- P/E 2027E
- 25.69x
- P/E 2028E
- 15.49x
- P/S forward
- 8.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- 214.65x
- PEG TTM
- 0.32x
- Price / book
- 17.10x
- Price / sales
- 14.52x
- Price / cash flow
- 109.99x
Enterprise value
- Enterprise value
- $11.8B
- EV / sales
- 14.16x
- EV / EBITDA
- 408.74x
- EV / EBIT
- 1837.18x
- Market cap
- $12.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026